• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下颌下腺肿瘤的术前评估与手术规划

Preoperative evaluation and surgical planning of submandibular gland tumors.

作者信息

Atula Timo, Panigrahi Juha, Tarkkanen Jussi, Mäkitie Antti, Aro Katri

机构信息

Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Department of Pathology, HUSLAB, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

出版信息

Head Neck. 2017 Jun;39(6):1071-1077. doi: 10.1002/hed.24691. Epub 2017 Mar 28.

DOI:10.1002/hed.24691
PMID:28370782
Abstract

BACKGROUND

Roughly half of submandibular gland neoplasms are malignant. Because preoperative information on the nature of these tumors remains limited, both preoperative evaluation and assessment of the extent of primary surgery warrant guidelines that are more accurate.

METHODS

We evaluated the preoperative examinations and management of all submandibular gland neoplasms treated surgically at the Helsinki University Hospital between 2000 and 2010.

RESULTS

Of the 83 tumors, 58 (70%) were benign and 25 (30%) were malignant. Of the benign tumors, 54 (93%) were pleomorphic adenomas. The cytology in 8 patients (10%) was class IV or V, and in 12 patients was class III; the tumors in 9 of these 12 patients turned out to be malignant. Of all malignancies, 10 (40%) required additional more extensive surgery.

CONCLUSION

Ultrasound-guided fine-needle aspiration cytology (FNAC) proved useful, with limitations, in preoperative examination. Surgeons should always obtain wide margins whenever possible, even when clinical means or cytology indicates no malignancy. © 2017 Wiley Periodicals, Inc. Head Neck 39: 1071-1077, 2017.

摘要

背景

大约一半的下颌下腺肿瘤是恶性的。由于这些肿瘤性质的术前信息仍然有限,术前评估和原发性手术范围的评估都需要更准确的指导方针。

方法

我们评估了2000年至2010年期间在赫尔辛基大学医院接受手术治疗的所有下颌下腺肿瘤的术前检查和处理情况。

结果

83例肿瘤中,58例(70%)为良性,25例(30%)为恶性。良性肿瘤中,54例(93%)为多形性腺瘤。8例患者(10%)的细胞学检查为IV级或V级,12例患者为III级;这12例患者中有9例的肿瘤最终被证实为恶性。在所有恶性肿瘤中,10例(40%)需要进行额外的更广泛手术。

结论

超声引导下细针穿刺细胞学检查(FNAC)在术前检查中证明是有用的,但有局限性。外科医生应尽可能始终获得足够宽的切缘,即使临床检查或细胞学检查未提示恶性。©2017威利期刊公司。《头颈》39: 1071 - 1077, 2017。

相似文献

1
Preoperative evaluation and surgical planning of submandibular gland tumors.下颌下腺肿瘤的术前评估与手术规划
Head Neck. 2017 Jun;39(6):1071-1077. doi: 10.1002/hed.24691. Epub 2017 Mar 28.
2
Submandibular gland cancer: Specific features and treatment considerations.下颌下腺癌:特殊特征及治疗考量
Head Neck. 2018 Jan;40(1):154-162. doi: 10.1002/hed.24981. Epub 2017 Oct 30.
3
Fine-needle aspiration cytology (FNAC): is it useful in preoperative diagnosis of parotid gland lesions?细针穿刺细胞学检查(FNAC):它在腮腺病变的术前诊断中有用吗?
Acta Chir Belg. 2017 Apr;117(2):110-114. doi: 10.1080/00015458.2016.1262491. Epub 2016 Dec 21.
4
Accuracy of fine needle aspiration cytology of salivary gland lesions: routine diagnostic experience in Bangkok, Thailand.涎腺病变细针穿刺细胞学检查的准确性:泰国曼谷的常规诊断经验
Asian Pac J Cancer Prev. 2012;13(4):1583-8. doi: 10.7314/apjcp.2012.13.4.1583.
5
Epithelial-Myoepithelial Carcinoma of the Submandibular Gland: Case Report.颌下腺上皮-肌上皮癌:病例报告。
J Nippon Med Sch. 2021;88(3):238-241. doi: 10.1272/jnms.JNMS.2021_88-309.
6
[Fine needle aspiration in salivary gland tumors: specificity and sensitivity].[唾液腺肿瘤的细针穿刺活检:特异性与敏感性]
Rev Assoc Med Bras (1992). 2007 May-Jun;53(3):267-71. doi: 10.1590/s0104-42302007000300027.
7
Pleomorphic multicentric adenoma in the submandibular gland.下颌下腺多形性多中心性腺瘤
Head Neck Pathol. 2007 Dec;1(2):178-80. doi: 10.1007/s12105-007-0037-y. Epub 2007 Dec 7.
8
Pleomorphic adenoma of an accessory submandibular salivary gland: a rare entity.副下颌下涎腺多形性腺瘤:一种罕见的实体。
Br J Oral Maxillofac Surg. 2015 Oct;53(8):e33-5. doi: 10.1016/j.bjoms.2015.05.011. Epub 2015 Jun 27.
9
Primary tumors of the submandibular glands: a retrospective study based on 41 cases.下颌下腺原发性肿瘤:基于 41 例病例的回顾性研究。
Oral Oncol. 2010 Apr;46(4):287-91. doi: 10.1016/j.oraloncology.2010.01.011. Epub 2010 Feb 26.
10
[Diagnostic accuracy and pitfalls in fine needle aspiration cytology of salivary glands: a study of 113 cases].[唾液腺细针穿刺细胞学检查的诊断准确性及陷阱:113例研究]
Zhonghua Bing Li Xue Za Zhi. 2005 Nov;34(11):706-10.

引用本文的文献

1
Frozen Section Analysis in Submandibular Gland Tumors: Optimizing Intraoperative Decision-Making.下颌下腺肿瘤的冰冻切片分析:优化术中决策
Cancers (Basel). 2025 Mar 5;17(5):895. doi: 10.3390/cancers17050895.
2
Epidemiology, outcomes, and prognostic factors in submandibular gland carcinomas: a national DAHANCA study.颌下腺癌的流行病学、结局和预后因素:一项全国性 DAHANCA 研究。
Eur Arch Otorhinolaryngol. 2023 Jul;280(7):3405-3413. doi: 10.1007/s00405-023-07940-y. Epub 2023 Apr 13.
3
[Frozen section biopsy for tumors of the submandibular triangle].
[下颌下三角区肿瘤的冰冻切片活检]
HNO. 2023 Mar;71(3):164-169. doi: 10.1007/s00106-022-01240-3. Epub 2022 Nov 14.
4
Needle biopsy compared with surgical biopsy: pitfalls of small biopsy in histologial diagnosis of IgG4-related disease.针吸活检与手术活检:IgG4 相关疾病组织学诊断中小活检的陷阱。
Arthritis Res Ther. 2021 Feb 10;23(1):54. doi: 10.1186/s13075-021-02432-y.
5
Preoperative evaluation and treatment consideration of parotid gland tumors.腮腺肿瘤的术前评估与治疗考量
Laryngoscope Investig Otolaryngol. 2020 Jul 20;5(4):694-702. doi: 10.1002/lio2.433. eCollection 2020 Aug.
6
Repeatedly recurring pleomorphic adenoma: a therapeutic challenge.复发性多形性腺瘤:一项治疗挑战。
Acta Otorhinolaryngol Ital. 2019 Jun;39(3):156-161. doi: 10.14639/0392-100X-2307.
7
Prediction of malignancy of submandibular gland tumors with apparent diffusion coefficient.基于表观扩散系数预测下颌下腺肿瘤的良恶性。
Oral Radiol. 2019 Jan;35(1):11-15. doi: 10.1007/s11282-017-0311-y. Epub 2017 Dec 29.
8
Pleomorphic Adenoma Originating from Heterotopic Salivary Tissue of the Upper Neck: A Diagnostic Pitfall.起源于上颈部异位涎腺组织的多形性腺瘤:诊断陷阱
Case Rep Otolaryngol. 2017;2017:5767396. doi: 10.1155/2017/5767396. Epub 2017 Nov 15.